Skip to main content
HR 133 118th Congress House Health Medical research Medicare Prescription drugs

MERIT Act

Introduced: August 25, 2023 Introduced by: Buchanan, Vern Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2024
Committee on Ways and Means discharged.
Dec 19, 2024
Placed on the Union Calendar, Calendar No. 779.
Dec 17, 2024
Referred to the Subcommittee on Health.
Nov 22, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
Nov 22, 2024
House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
Dec 6, 2023
Committee Consideration and Mark-up Session Held
Dec 6, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
Dec 5, 2023
Committee Consideration and Mark-up Session Held
Nov 15, 2023
Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.
Nov 15, 2023
Subcommittee Consideration and Mark-up Session Held
Jan 20, 2023
Referred to the Subcommittee on Health.
Jan 9, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 9, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Mandating Exclusive Review of Individual Treatments (MERIT) Act

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.

What's happening now December 19, 2024

Placed on the Union Calendar, Calendar No. 779.

 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Lobbying activity 10

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

See all 10 filings →
 Cosponsors 6
All 6 Democratic 1 Republican 4
R
Miller, Carol D.
West Virginia · Aug 25, 2023
 R
Carey, Mike
Ohio · May 11, 2023
Ferguson, A.
· May 10, 2023
 R
Fitzpatrick, Brian K.
Pennsylvania · May 9, 2023
 D
Barragán, Nanette Diaz
California · Jan 9, 2023
 R
Salazar, Maria Elvira
Florida · Jan 9, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 133: MERIT Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-133/
MLA
"H.R. 133: MERIT Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-133/.
Bluebook (legal)
H.R. 133, 118th Cong. (2026), https://openamerica.io/bill/118-HR-133/.
Markdown link
[H.R. 133: MERIT Act](https://openamerica.io/bill/118-HR-133/)
Report a problem